arrow
J

John K. Lee

University of California Los Angeles
H指数:45
被引数:7,716

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

tRNA dosage regulates lineage dependency and resistance in prostate cancer

tRNA剂量调控前列腺癌细胞谱系依赖性和耐药性

Nature
IF48.5
2026-10-070
OA
Recurrent prostate adenocarcinoma after radical prostatectomy: Principles of multidisciplinary management across a spectrum of disease

根治性前列腺切除术后的复发性前列腺腺癌:不同疾病阶段的多学科管理原则

2026-09-290
OAAI
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes

致死性转移性膀胱癌亚型的演化和异质性

Nature
IF48.5
2026-09-160
OAAI
Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancer

系统分析 Hippo 通路信号传导确定了 TEAD1 是神经内分泌前列腺癌的转录调控因子

2026-05-300
OAAI
Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering

通过捕捉键工程克服T细胞对肿瘤自身抗原的耐受性

Science
IF45.8
2026-03-190
PRE
Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse models

胶原蛋白结合IL-12装甲STEAP1 CAR-T细胞可降低毒性并治疗小鼠模型中的前列腺癌

2025-10-230
OAAI
Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery

靶向PD-L1的融合蛋白工程化改造的实体瘤CAR-T细胞,用于局部IL-12递送

2025-10-010
OAAI
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

通过调节PPARγ通路上调NECTIN4,并增强膀胱癌中嵌合抗原受体(CAR)T细胞疗法。Nat. Commun. 16 (1), 8215

2025-09-100
OAAI
Functional, sustained recovery of hearing in Otoferlin-deficient mice using DB-OTO, a hair cell-specific AAV based dual vector gene therapy

使用DB-OTO(一种基于毛细胞特异性AAV的双载体基因疗法)实现 otoferlin 缺陷小鼠功能性、持续性的听力恢复

2025-08-250
OAAI
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity
2024-11-260
OAAI
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
2024-05-173
OAAI
Multiomic characterization of colorectal cancer using MICS technology reveals interaction of antigen presenting cancer associated fibroblasts and T cells
2024-03-220
PRE
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models

肿瘤衍生的生物标志物预测B7H3抗体-药物偶联物治疗转移性前列腺癌模型的疗效

2023-11-153
OAAI